Year: 2020
Type: review
Abstract: To provide better prevention and treatment, we need to understand the environmental and genetic risks of Alzheimer's disease (AD). However, the definition of AD has been confounded with dementia in many studies. Thus, overinterpretation of genetic findings with regard to mechanisms and drug targets may explain, in part, controversies in the field. Here, we analyze the different forms of genetic risk of AD and how these can be used to model disease. We stress the importance of studying gene variants in the right cell types and in the right pathological context. The lack of mechanistic understanding of genetic variation has become the major bottleneck in the search for new drug targets for AD.
Source: Science
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Alzheimer's Association, EU Joint Programme – Neurodegenerative Disease Research, Llywodraeth Cymru, Alzheimer's Society, European Commission, Fonds Wetenschappelijk Onderzoek, KU Leuven, Vlaams Instituut voor Biotechnologie, Internationale Stichting Alzheimer Onderzoek, UK Dementia Research Institute, Fondation pour la Recherche sur Alzheimer, Medical Research Council, H2020 European Research Council
OpenAlex ID: W3090238527
